Breaking News
November 20, 2018 - Karyopharm’s Selinexor Receives Fast Track Designation from FDA for the Treatment of Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma
November 20, 2018 - Arthritis by the Numbers: Book of Trusted Facts & Figures
November 20, 2018 - Drug homing method helps rethink Parkinson’s
November 20, 2018 - AHF commends the passage of global AIDS funding in the House, calls for swift approval
November 20, 2018 - The search for new psychiatric disorder treatments
November 20, 2018 - New research offers hope for simpler way to diagnose and treat cancer
November 20, 2018 - Study sheds light on the infection mechanism of influenza virus
November 20, 2018 - Storage failures of eggs and embryos gain a new perspective
November 20, 2018 - Buyers of short-term health plans: Wise or shortsighted?
November 20, 2018 - Study indicates that frogs in virus-exposed groups breed at young age
November 20, 2018 - FDA Alerts Health Care Professionals and Patients Not To Use Sterile Drug Products from Pharm D Solutions
November 20, 2018 - Asthma may contribute to childhood obesity epidemic
November 20, 2018 - Researchers to explore the enigmatic role of unstructured protein in regulating circadian function
November 20, 2018 - Drug used to treat PTSD does not reduce suicidal thinking, may worsen nightmares and insomnia
November 20, 2018 - In-person social contact may offer protection against depression and PTSD symptoms
November 20, 2018 - Routine HCV testing in correctional facilities can best identify and treat disease, say researchers
November 20, 2018 - Molecular DNA analysis could facilitate more accurate prognosis, treatment of aggressive brain tumors
November 20, 2018 - Breast Cancer Recurrence Rate Not Up With Autologous Fat Transfer
November 20, 2018 - Beta 2 Microglobulin (B2M) Tumor Marker Test: MedlinePlus Lab Test Information
November 20, 2018 - Could bariatric surgery make men more virile?
November 20, 2018 - Urine test to check if patients take their medications will save the NHS money, say researchers
November 20, 2018 - Study reveals impact of residual inflammatory risk on clinical outcomes after PCI
November 20, 2018 - RNAi therapy shown to alleviate preeclampsia
November 20, 2018 - Replacement of dysfunctional microglia has therapeutic potential for neurodegenerative diseases
November 20, 2018 - Forming 3D Neuronal Models of the Brain
November 20, 2018 - Shoulder ultrasounds could be used to predict diabetes
November 20, 2018 - SGLT2 Inhibitors for Diabetes Linked to Increased Risk for Amputation
November 20, 2018 - Stem cell transplant cements Arizona men’s father-son bond
November 20, 2018 - Scientists try to develop portable systems that can quickly produce biologics on demand
November 20, 2018 - Automating Data Capture and Image Analysis in Continuous Experiments
November 20, 2018 - New drug shows promise for treating people with peanut allergy
November 20, 2018 - Researchers develop novel mouse model to study immunomodulatory therapies
November 20, 2018 - “Britain must not go backward on antibiotic controls to appease US trade deals” – Jim Moseley, CEO of Red Tractor
November 20, 2018 - Widespread errors in ‘proofreading’ cause inherited blindness
November 20, 2018 - Reaping the benefits of living longer
November 20, 2018 - New Program Hopes to Make Early Detection and Treatment of ALS a Reality
November 19, 2018 - Artificial bone-like substance mimics the way real bone grows at atomic level
November 19, 2018 - FDA Grants Orphan Drug Designation To RGX-181 Gene Therapy For The Treatment Of CLN2 Form Of Batten Disease
November 19, 2018 - Systemic mastocytosis – Genetics Home Reference
November 19, 2018 - Eye trauma secondary to falls in older adults increasing
November 19, 2018 - Empowering women in India to improve their health: A Q&A
November 19, 2018 - Researchers have trained a computer to analyze breast cancer images and classify tumors
November 19, 2018 - New glucose binding molecule could be key to better metabolic control for diabetics
November 19, 2018 - Biologists uncover novel genetic control of lipid maintenance and its potential connection to lifespan
November 19, 2018 - Warmer winters may set scene for higher rates of violent crimes
November 19, 2018 - Personalized program of physical exercise effective in reversing functional decline in the elderly
November 19, 2018 - Acacia Pharma Resubmits Barhemsys New Drug Application
November 19, 2018 - PDL1 (Immunotherapy) Tests: MedlinePlus Lab Test Information
November 19, 2018 - Transforming pregnancy research with a smartphone app
November 19, 2018 - Stanford Medicine magazine explores how digital technology is changing health care
November 19, 2018 - Vision impairments may increase risk of falls in older adults
November 19, 2018 - Concomitant use of sleeping pills and opioids found to prevalent among people with Alzheimer’s disease
November 19, 2018 - Marijuana prevention programs should focus on promoting mental wellbeing of youth
November 19, 2018 - New report calls for greater awareness and emphasis on scale and impact of atrial fibrillation
November 19, 2018 - In throes of turkey salmonella outbreak, don’t invite illness to your table
November 19, 2018 - UK health policies should be redesigned to become more accessible for men
November 19, 2018 - Short Interpregnancy Intervals Tied to Adverse Outcome Risk
November 19, 2018 - New mothers’ breastfeeding pain can affect infant health
November 19, 2018 - Stanford Medicine magazine reports on ways digital technology is transforming health care | News Center
November 19, 2018 - Human drugs alter cricket personality
November 19, 2018 - Insilico Medicine to introduce ‘Cure a disease in a year’ program at Biodata World Congress 2018
November 19, 2018 - Experts debate over whether gut or brain is more important in regulating appetite
November 19, 2018 - Playing on fear and fun, hospitals follow pharma in direct-to-consumer advertising
November 19, 2018 - 2PG Company receives grant to develop sensitive, low-cost molecular diagnostic tests for tuberculosis
November 19, 2018 - Low-Carb Diets May Work By Boosting Calorie Burn
November 19, 2018 - Key molecule responsible for learning and memory discovered
November 19, 2018 - New blood test developed for early diagnosis of ovarian cancer
November 19, 2018 - Researchers identify molecule to fight myotubular myopathy
November 19, 2018 - New solution to stop spread of brain cancer
November 19, 2018 - Immune cells trigger OCD-like behaviour in multiple sclerosis, study finds
November 19, 2018 - Scientists equip new virus that kills carcinoma cells with protein
November 19, 2018 - Novel approach could provide painless, efficient alternative for treating eye diseases
November 19, 2018 - Protein in cell membranes of sperm plays key role in finding their way to eggs
November 19, 2018 - Parents who decline flu vaccination for their child may be exposed to limited information
November 19, 2018 - Mirati Presents Data From Ongoing Phase 2 Clinical Trial Of Mocetinostat In Combination With Durvalumab At The SITC 33rd Annual Meeting
November 19, 2018 - FDA warns of common diabetes meds’ link to dangerous genital infection
November 19, 2018 - New methods for preserving shoulder function, quality of life in breast cancer patients
November 19, 2018 - Surprising discovery about BH4 may rekindle interest in once-promising pathway
November 19, 2018 - Nabriva Therapeutics Completes Submission of New Drug Application to U.S. Food and Drug Administration for Intravenous Contepo to Treat Complicated Urinary Tract Infections
November 19, 2018 - Beating breast cancer only to die of opioid use – a sad Appalachian story
Heroin addiction treatment and opioid misuse

Heroin addiction treatment and opioid misuse

image_pdfDownload PDFimage_print
Michael Fendrich, associate dean for research and professor at the School of Social Work, on Oct. 12, 2018. Credit: Sean Flynn/UConn Photo

Michael Fendrich is associate dean for research and a professor in the UConn School of Social Work, whose research focuses on policies, services, interventions, and risk factors related to substance misuse and mental health. He recently published a paper about heroin addiction treatment and how it relates to previous opioid misuse history.

Fendrich joined the UConn faculty in 2014, and was previously the director of the Center of Applied Behavioral Health Research at the University of Wisconsin-Milwaukee from 2005 to 2013. He discussed his latest study with UConn Today.

Q. How did you first get interested in the topic of heroin addiction and how it relates to previous opioid history?

A. The increased awareness of the opioid epidemic started five or six years ago, and states were implementing – at the encouragement of the federal government – prescription drug monitoring programs. I was in Milwaukee at the time and was collaborating with a school of pharmacy. I became aware that Wisconsin was one of the last states to implement a prescription drug monitoring program.

I thought this might be a really good opportunity to interview pharmacists and get a sense of what they know about substance abuse and how they view the prescription drug monitoring program. They often come at things with a medical perspective, and – I don’t want to say this in a pejorative way – they don’t always have a clear understanding of some of the behavioral factors. It’s not their world.

It made me interested in figuring out how they would view the opioid crisis, and how they would view the potential issues around people misusing prescription medications, and what their overall knowledge level was about addiction and substance abuse.

In focus groups, we heard things like ‘sometimes I feel like I am more of a policeman than a pharmacist.’ Some pharmacists felt like law enforcement, some felt like health care providers, and some pharmacists felt like they are somewhere in the middle.

Q. What were some of your main findings in your most recent paper on this topic?

A. The big finding was that people [who were undergoing heroin addiction treatment] who had prior opioid history were generally more substance-involved, and they were involved earlier in those substances. They were also more persistent in their opioid use. And they were more likely to suffer some elevated symptoms of depression. So basically, the folks who were heroin dependent with that prior history had more problems than others and they didn’t do as well.

The issue is, does it makes a difference? Yes, it probably does. Those people who progressed in the typical story line that has been described, with opioids and heroin, probably have a more difficult outcome, and – in terms of the potential difficulty of getting us out of this crisis – it points to how problematic this is. It is not just one opioid problem out there, it’s what people’s history contributes to making this a more intractable problem. There are other mental health issues that need to be addressed, especially depression – it’s not just the substance abuse, which everyone is focused on. These mental health issues may mean you need to tailor how you are treating folks. We need other types of intervention that address the conditions people have, especially those that have opioid use before their heroin abuse.

Q. How did this opioid problem get so severe in our society?

A. The story people tell is well-known – an increased availability in prescribed opioid-related medications. That is part of the story. We have other issues going on in society, like lack of opportunity in terms of economic mobility and jobs. There are lots of stressors going on in society and I think those macro-forces have to be considered part of the picture. Everyone says we have a great economy now, but there are a lot of folks who are underemployed, not earning sufficient wages, or don’t have rewarding job opportunities. They haven’t had access to training, and this crosscuts all ethnic groups and all regions: it’s rural, it’s urban.

It’s not, in my opinion, one particular thing that got us into this, and I will also note, there is not going to be one particular thing that’s going to get us out of it. We are going to have to have policies that create job training opportunities, and have access to health care, and access to resources for everybody. We are also going to have to have more restrictive policies toward opioid drugs and opioid drug availability, but by the same token, some of these opioid drugs have been quite beneficial in terms of facilitating pain relief for debilitating conditions. It just needs to be regulated in a way that doesn’t enhance potential for abuse.

Q. So is there hope?

A. Yes, I think so. It is so much on the public radar screen right now. Congress just allocated resources to expand access to treatment. The states, and here in Connecticut the DMHAS (Department of Mental Health and Addiction Services), have been the beneficiary of millions of dollars of funding from the federal government to address the problem. We do have treatment interventions in the form of medication. We have medication to address overdose, like naloxone. It seems like awareness is at a level where it needs to be if we are going to address the problem. The downside is that it seems like in Connecticut and elsewhere, the number of overdose deaths is really very high, and our rates are above the national average in Connecticut in almost every county.

Q. What are you working on now?

A. We are finishing work on a totally different topic – emergency mobile crisis services for children with acute mental health needs. There is a statewide system for kids with this need, and it diverts them from hospital emergency departments. We have a grant to evaluate these services, and whether in fact there is a successful diversion of these kids from the ER. I am really excited about that study.


Explore further:
Any opioid use tied to involvement in criminal justice system

Provided by:
University of Connecticut

Tagged with:

About author

Related Articles